相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular mechanisms and physiological functions of mitophagy
Mashun Onishi et al.
EMBO JOURNAL (2021)
PRDX3 is associated with metastasis and poor survival in uveal melanoma
Pathma Ramasamy et al.
JOURNAL OF CLINICAL PATHOLOGY (2020)
Redox homeostasis, oxidative stress and mitophagy
Carla Garza-Lombo et al.
MITOCHONDRION (2020)
Systematic Characterization of Prognostic Values of Peroxiredoxin Family in Gastric Cancer
Rui Xu et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Knockout of PRDX6 induces mitochondrial dysfunction and cell cycle arrest at G2/M in HepG2 hepatocarcinoma cells
Maria Jose Lopez-Grueso et al.
REDOX BIOLOGY (2020)
Peroxiredoxin 2 is highly expressed in human oral squamous cell carcinoma cells and is upregulated by human papillomavirus oncoproteins and arecoline, promoting proliferation
Jureeporn Chuerduangphui et al.
PLOS ONE (2020)
Head and Neck Cancer
Laura Q. M. Chow
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Up-regulation of peroxiredoxin-1 promotes cell proliferation and metastasis and inhibits apoptosis in cervical cancer
Ermei Lu et al.
JOURNAL OF CANCER (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Survival outcomes after treatment of cancer of the oral cavity (1985-2015)
Daniella Karassawa Zanoni et al.
ORAL ONCOLOGY (2019)
Peroxiredoxin-1 as a prognostic factor in patients with ovarian cancer
Jacek Sienko et al.
ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE (2019)
Nicotine promotes cervical metastasis of oral cancer by regulating peroxiredoxin 1 and epithelial-mesenchymal transition in mice
Min Wang et al.
ONCOTARGETS AND THERAPY (2019)
Peroxiredoxin V Reduces β-Lapachone-induced Apoptosis of Colon Cancer Cells
Yue Liu et al.
ANTICANCER RESEARCH (2019)
Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression
Tayaba Ismail et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus
Yingying Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The Prognosis Of Peroxiredoxin Family In Breast Cancer
Gang Wang et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients
Bing Bai et al.
ONCOLOGY REPORTS (2019)
The broken cycle: E2F dysfunction in cancer
Lindsey N. Kent et al.
NATURE REVIEWS CANCER (2019)
The Role of Peroxiredoxin Family in Cancer Signaling
Yosup Kim et al.
JOURNAL OF CANCER PREVENTION (2019)
Oral cancer databases: A comprehensive review
Gargi S. Sarode et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2018)
Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer
Mark B. Hampton et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
The Role of Peroxiredoxins in the Transduction of H2O2 Signals
Sue Goo Rhee et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches
Chukkris Heawchaiyaphum et al.
JOURNAL OF PROTEOMICS (2018)
Peroxiredoxin 1 promoted tumor metastasis and angiogenesis in colorectal cancer
Huan-Xi Li et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
High Expression of Peroxiredoxin 1 Is Associated with Epithelial-Mesenchymal Transition Marker and Poor Prognosis in Gastric Cancer
Wei Yu et al.
MEDICAL SCIENCE MONITOR (2018)
Peroxiredoxin 1 (PRDX1) Suppresses Progressions and Metastasis of Osteosarcoma and Fibrosarcoma of Bone
Yongxiang Wang et al.
MEDICAL SCIENCE MONITOR (2018)
Decreased expression of peroxiredoxin I inhibits proliferation, invasion, and metastasis of ovarian cancer cell
Ming-Jun Zheng et al.
ONCOTARGETS AND THERAPY (2018)
Clinical analysis of neck node metastasis in oral cavity cancer
Aditi Sharma et al.
JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS (2018)
Reactive oxygen species and cancer paradox: To promote or to suppress?
Sehamuddin Galadari et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Peroxiredoxin-1 promotes cell proliferation and metastasis through enhancing Akt/mTOR in human osteosarcoma cells
An-Lie Cai et al.
Oncotarget (2017)
Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients
LingLong Peng et al.
ONCOTARGET (2017)
Mitochondria and cancer chemoresistance
Flora Guerra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2017)
Peroxiredoxin 5 promotes the epithelial-mesenchymal transition in colon cancer
Hye-Mi Ahn et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Peroxiredoxin 1 (Prx1) is a dual-function enzyme by possessing Cys-independent catalase-like activity
Cen-Cen Sun et al.
BIOCHEMICAL JOURNAL (2017)
Endogenous DNA Damage as a Source of Genomic Instability in Cancer
Anthony Tubbs et al.
CELL (2017)
The role of peroxiredoxins in cancer
Arianna Nicolussi et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Overview on Peroxiredoxin
Sue Goo Rhee
MOLECULES AND CELLS (2016)
Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy
Barbara Marengo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
ROS homeostasis and metabolism: a dangerous liason in cancer cells
E. Panieri et al.
CELL DEATH & DISEASE (2016)
Peroxiredoxin 1 promotes invasion and migration by regulating epithelial-to-mesenchymal transition during oral carcinogenesis
Wenwen Niu et al.
ONCOTARGET (2016)
Distant metastasis from oral cancer: A review and molecular biologic aspects
Soussan Irani
JOURNAL OF INTERNATIONAL SOCIETY OF PREVENTIVE AND COMMUNITY DENTISTRY (2016)
Expression of cyclooxygenase-2, peroxiredoxin I, peroxiredoxin 6 and nuclear factor-κB in oral squamous cell carcinoma
Eun-Young Lee et al.
ONCOLOGY LETTERS (2015)
Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma
Qi-Kai Sun et al.
MEDICAL ONCOLOGY (2014)
Mitochondrial reactive oxygen species and cancer
Lucas B. Sullivan et al.
CANCER & METABOLISM (2014)
Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress
H. C. Whitaker et al.
BRITISH JOURNAL OF CANCER (2013)
Dual Role of the Antioxidant Enzyme Peroxiredoxin 6 in Skin Carcinogenesis
Frank Rolfs et al.
CANCER RESEARCH (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy
In-Sung Song et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Increased expression of peroxiredoxin 6 and cyclophilin A in squamous cell carcinoma of the tongue
C-F Huang et al.
ORAL DISEASES (2011)
分享论文
